DKA in nursing: pathophysiology, assessment, and management

Diabetic ketoacidosis (DKA) is a life-threatening metabolic emergency that requires rapid recognition and aggressive intervention. It develops when severe insulin deficiency forces the body to break down fat for energy, producing ketone acids that overwhelm the blood’s buffering capacity and drive pH dangerously low. DKA carries a mortality rate of 0.2–2.5% even with treatment, and delays in recognition make outcomes significantly worse.

For nursing students, DKA is high-yield clinical content. You will encounter it on NCLEX, on the med-surg floor, and in the emergency department. This reference covers the complete pathophysiology cascade, diagnostic criteria by severity, the critical DKA versus HHS distinction, nursing assessment priorities, the three pillars of management (fluids, insulin, electrolytes), and the complications you must monitor during treatment. Use this alongside the nursing lab values cheat sheet and the electrolyte imbalances reference for a solid endocrine emergency library.

Pathophysiology of DKA

DKA develops through a predictable cascade that begins with insulin deficiency and ends with severe metabolic acidosis, dehydration, and electrolyte depletion. Understanding each step explains every clinical finding and every intervention.

Step 1: insulin deficiency and counterregulatory hormone surge

The process starts when circulating insulin drops to critically low levels. In type 1 diabetes, this happens because autoimmune destruction of pancreatic beta cells eliminates insulin production. In type 2 diabetes, it can occur during severe physiologic stress (sepsis, myocardial infarction, trauma) when counterregulatory hormones overwhelm whatever insulin remains.

When insulin falls, the body interprets the situation as starvation — even though blood glucose is elevated. Counterregulatory hormones surge: glucagon, cortisol, catecholamines, and growth hormone all rise. These hormones increase hepatic glucose production through glycogenolysis (breaking down glycogen) and gluconeogenesis (synthesizing new glucose from amino acids and lactate). Simultaneously, insulin’s normal suppression of these pathways is absent. Blood glucose rises rapidly.

Step 2: lipolysis and ketogenesis

Without insulin to facilitate glucose uptake into cells, the body turns to fat as its primary fuel source. Counterregulatory hormones activate hormone-sensitive lipase in adipose tissue, releasing free fatty acids (FFAs) into the bloodstream at a rate the liver cannot handle through normal oxidation pathways.

The liver converts these FFAs into ketone bodies: beta-hydroxybutyrate, acetoacetate, and acetone. In controlled amounts, ketones are a normal alternative fuel. In DKA, production far exceeds the body’s capacity to use or excrete them. Ketone acids accumulate, consuming bicarbonate buffers and driving arterial pH downward. This is the metabolic acidosis that defines DKA.

Step 3: osmotic diuresis and dehydration

As blood glucose climbs above the renal threshold (~180 mg/dL), glucose spills into the urine. Glucose is osmotically active — it pulls water with it, producing the polyuria that patients report. This osmotic diuresis can cause fluid losses of 5–10 liters. Along with water, the kidneys excrete sodium, potassium, chloride, phosphate, and magnesium. The result is profound dehydration and total-body electrolyte depletion.

Step 4: electrolyte shifts

Potassium handling in DKA is particularly dangerous and frequently tested on NCLEX. Total-body potassium is severely depleted from osmotic diuresis. However, serum potassium often appears normal or even elevated on initial labs. This occurs because acidosis drives potassium out of cells (hydrogen ions move intracellularly, potassium moves extracellularly to maintain electrical neutrality) and because insulin deficiency removes the normal stimulus for cellular potassium uptake. The moment you give insulin, potassium shifts back into cells and serum levels can plummet. This is why potassium replacement must begin before or simultaneously with insulin therapy — and why insulin is held entirely when K+ is below 3.5 mEq/L.

Step 5: the spiral worsens

Dehydration reduces renal perfusion, which decreases the kidneys’ ability to excrete glucose and ketones — making both accumulate faster. Acidosis impairs cardiac contractility and peripheral vascular tone, worsening hypotension. Acetone produces the characteristic fruity breath odor. The brainstem responds to severe acidosis with Kussmaul respirations — deep, labored breathing that increases CO2 exhalation to compensate for the metabolic acid load. If untreated, progressive acidosis leads to obtundation, coma, and death.

DKA versus HHS: key differences

Distinguishing DKA from hyperglycemic hyperosmolar state (HHS) is one of the most commonly tested NCLEX concepts in endocrine nursing. Both are hyperglycemic emergencies, but they differ in mechanism, presentation, and urgency.

The critical distinction: in HHS, the patient retains enough endogenous insulin to prevent lipolysis and ketone production, so acidosis does not develop. The primary danger in HHS is extreme hyperosmolality and dehydration rather than acid-base imbalance. Both emergencies share the same treatment principles (fluids, insulin, electrolytes), but HHS patients are typically older, more dehydrated, and have higher mortality.

Precipitating factors

Identifying the precipitating factor is essential because treating DKA without addressing the underlying trigger leads to recurrence. The most commonly tested precipitants follow the mnemonic of the “5 I’s,” though infection and insulin nonadherence account for the vast majority of cases.

• Infection — the most common trigger. Pneumonia and urinary tract infections top the list. The stress response to infection increases counterregulatory hormones and insulin resistance.
• Insufficient insulin — missed doses, insulin pump failure, or deliberate insulin omission (sometimes seen in eating disorders). This is the most common preventable cause and a key patient education target.
• Ischemia — myocardial infarction, stroke, or mesenteric ischemia. The physiologic stress response drives counterregulatory hormone release.
• Intoxication — cocaine is an independent risk factor for recurrent DKA. Alcohol can contribute through dehydration and poor self-care.
• Iatrogenic — corticosteroids (raise blood glucose significantly), SGLT-2 inhibitors (can cause euglycemic DKA with glucose <250 mg/dL), and immune checkpoint inhibitors (can trigger new-onset autoimmune diabetes).

Other precipitants include new-onset type 1 diabetes (DKA is the initial presentation in approximately 25% of cases), pregnancy (euglycemic DKA risk), pancreatitis, and trauma.

Clinical presentation and assessment findings

DKA presents with a combination of hyperglycemia symptoms, acidosis signs, and dehydration markers. Each finding connects directly to the underlying pathophysiology.

Hyperglycemia-related findings

• Polyuria — osmotic diuresis from glucosuria pulls water into the urine. Patients report frequent, high-volume urination.
• Polydipsia — dehydration from osmotic diuresis triggers intense thirst.
• Polyphagia — cells cannot access glucose for energy despite high blood levels, triggering hunger signals. This symptom is more prominent in the early stages; nausea often replaces it as acidosis worsens.
• Blurred vision — osmotic changes in the lens from hyperglycemia alter light refraction.
• Fatigue and weakness — cells are starved of their primary fuel source.

Acidosis-related findings

• Kussmaul respirations — deep, rapid, labored breathing. This is the respiratory system’s attempt to compensate for metabolic acidosis by blowing off CO2 (lowering PaCO2 to raise pH). Kussmaul breathing is a hallmark of DKA and does not occur in HHS.
• Fruity (acetone) breath — acetone, a volatile ketone body, is exhaled through the lungs. This is a classic textbook finding, though it may be subtle or absent in clinical practice.
• Nausea, vomiting, and abdominal pain — acidosis irritates the GI tract and can mimic an acute abdomen. Abdominal pain in DKA resolves with correction of acidosis. Important: do not pursue surgical evaluation for abdominal pain until DKA is treated, as pain typically resolves with metabolic correction.
• Altered mental status — ranges from mild confusion to frank coma depending on severity. Mental status correlates more closely with serum osmolality than with pH.

Dehydration-related findings

• Tachycardia — compensatory response to hypovolemia.
• Hypotension — from volume depletion (5–10 L fluid deficit is common). Orthostatic vital signs may be positive before frank hypotension develops.
• Dry mucous membranes and poor skin turgor — direct signs of fluid deficit.
• Sunken eyes and delayed capillary refill — signs of moderate to severe dehydration.
• Decreased urine output — occurs late as renal perfusion drops despite earlier polyuria.

Diagnostic criteria: DKA severity classification

The American Diabetes Association classifies DKA into mild, moderate, and severe categories based on laboratory values and mental status. This classification guides the intensity of monitoring and treatment setting.

Anion gap calculation: Na+ − (Cl− + HCO3−). Normal is 8–12 mEq/L. An elevated anion gap confirms the presence of unmeasured anions — in DKA, these are the ketone acids beta-hydroxybutyrate and acetoacetate. Refer to the nursing lab values cheat sheet for a full breakdown of metabolic panel interpretation.

Euglycemic DKA: A critical concept — DKA can occur with blood glucose below 250 mg/dL. This is most commonly associated with SGLT-2 inhibitor use (empagliflozin, dapagliflozin, canagliflozin) and pregnancy. The glucose level may appear reassuring while the patient is in severe acidosis. The lesson: always check for ketones and acidosis in patients on SGLT-2 inhibitors who present with nausea, vomiting, or malaise, regardless of glucose level.

Nursing assessment priorities

When a patient presents with suspected or confirmed DKA, systematic assessment drives every subsequent intervention. These are the priority assessments in order of clinical urgency.

Airway and breathing

Assess respiratory rate, depth, and pattern. Kussmaul respirations (deep, rapid, unlabored) are compensatory — they indicate the body is attempting to correct acidosis by eliminating CO2. A shift from Kussmaul to shallow, slow breathing in a patient with uncorrected acidosis is ominous: it suggests respiratory muscle fatigue or central nervous system depression and may indicate the need for intubation.

Monitor SpO2 continuously. Although DKA is a metabolic problem, severe dehydration and acidosis impair oxygen delivery to tissues. If the precipitating factor is pneumonia, respiratory status may deteriorate independently of the metabolic correction.

Neurological status

Assess level of consciousness using the Glasgow Coma Scale at baseline and at regular intervals (every 1–2 hours during active treatment). Mental status changes in DKA correlate with serum osmolality. A patient who becomes more confused during treatment — especially a pediatric patient — should raise immediate concern for cerebral edema (see Complications below).

Cardiovascular assessment

Continuous cardiac monitoring is essential. Electrolyte imbalances in DKA — particularly potassium — cause ECG changes that can progress to lethal arrhythmias. Review the EKG interpretation cheat sheet for a refresher on electrolyte-related ECG findings.

Assess heart rate, blood pressure (including orthostatic changes), and peripheral perfusion. Tachycardia with bounding pulses early in DKA reflects sympathetic compensation. Tachycardia with weak, thready pulses and hypotension suggests severe volume depletion requiring aggressive fluid resuscitation.

Fluid status

• Intake and output — strict monitoring. Insert a Foley catheter if the patient is obtunded or unable to report urine output reliably.
• Daily weight — the most reliable indicator of fluid balance.
• Skin turgor, mucous membranes, capillary refill — assess dehydration severity.
• Hourly urine output — target at least 0.5 mL/kg/hour as a sign of adequate renal perfusion.

Laboratory monitoring schedule

During active DKA management, expect to monitor these labs on a defined schedule:

• Blood glucose — every 1 hour (bedside glucometer and periodic venous confirmation)
• Basic metabolic panel (BMP) — every 2–4 hours (sodium, potassium, chloride, bicarbonate, BUN, creatinine, glucose)
• Venous blood gas — every 2–4 hours until pH normalizes (venous pH is acceptable for monitoring; arterial is needed at baseline)
• Serum ketones — every 4–6 hours (beta-hydroxybutyrate is preferred over urine ketones for accuracy)
• Magnesium and phosphate — every 6–8 hours

Nursing interventions and medical management

DKA treatment rests on three pillars: fluid resuscitation, insulin therapy, and electrolyte replacement. Each pillar has specific nursing considerations that are frequently tested on NCLEX.

Pillar 1: IV fluid resuscitation

Fluid resuscitation is the first intervention — it begins before insulin in most protocols. The average fluid deficit in DKA is 5–7 liters. Restoring intravascular volume improves renal perfusion, enhances glucose excretion, and reduces counterregulatory hormone levels.

Pillar 2: insulin therapy

Insulin is the definitive treatment because it stops ketogenesis. Regular insulin is given as a continuous IV infusion — rapid-acting analogs (lispro, aspart) are only used subcutaneously for mild DKA in some protocols.

Key nursing points:

• Hold insulin if serum potassium is below 3.5 mEq/L. Insulin drives potassium intracellularly. Giving insulin to a hypokalemic patient can cause fatal cardiac arrhythmias. Replace potassium first and recheck before starting the drip. This is one of the most critical safety points in DKA management.
• Standard protocol: 0.1 units/kg/hour continuous IV infusion (some protocols include a 0.1 units/kg bolus first; others use 0.14 units/kg/hour without bolus).
• Blood glucose should drop by 50–75 mg/dL per hour. If it is not dropping at this rate after the first hour, double the infusion rate.
• When glucose reaches 200–250 mg/dL: reduce the insulin rate to 0.05 units/kg/hour and add dextrose-containing fluids. The goal is to keep glucose between 150–200 mg/dL while insulin continues clearing ketones.
• Do NOT stop insulin when glucose normalizes. Insulin must continue until the anion gap closes and acidosis resolves. Stopping insulin prematurely because glucose is “fine” will cause ketone reaccumulation and a return to acidosis.
• Transition to subcutaneous insulin: Once DKA has resolved (see resolution criteria below), give the first dose of subcutaneous insulin and continue the IV infusion for at least 2 hours to prevent rebound ketoacidosis during the absorption gap.

Pillar 3: electrolyte replacement

Electrolyte management in DKA is where nursing vigilance saves lives. Total-body stores are depleted, but serum levels may be misleadingly normal on admission.

DKA resolution criteria

DKA is considered resolved when blood glucose falls below 200 mg/dL plus at least two of the following:

• Serum bicarbonate ≥15 mEq/L
• Venous pH >7.3
• Anion gap ≤12 mEq/L

Until all criteria are met, insulin infusion must continue even if blood glucose has normalized (use dextrose-containing fluids to prevent hypoglycemia). This is a common source of clinical error — treating the glucose number rather than the underlying acidosis.

Complications during DKA treatment

Successful DKA management requires anticipating and monitoring for treatment-related complications. Several of these are iatrogenic — caused by the treatment itself.

Cerebral edema

The most feared complication, particularly in pediatric patients and young adults. Cerebral edema develops in 0.5–1% of pediatric DKA episodes and carries a mortality rate of 20–25%. Risk factors include rapid fluid administration, rapid correction of hyperglycemia, and new-onset diabetes. Signs include sudden headache, vomiting, altered consciousness, bradycardia, and hypertension (Cushing response). If suspected, reduce IV fluid rate immediately, elevate the head of bed, and administer mannitol or hypertonic saline per provider orders.

Hypokalemia

The most frequent complication of DKA treatment. As insulin drives potassium intracellularly and acidosis corrects (allowing potassium to return to cells), serum potassium can drop precipitously. Severe hypokalemia causes cardiac arrhythmias, respiratory muscle weakness, and cardiac arrest. Continuous telemetry monitoring and serial potassium checks every 2 hours during active treatment are essential.

Hypoglycemia

Occurs in 5–25% of patients during DKA treatment. Results from continued insulin infusion after glucose normalizes without adequate dextrose supplementation. Monitor blood glucose hourly and transition to dextrose-containing fluids when glucose reaches 200–250 mg/dL.

Hyperchloremic metabolic acidosis

Occurs in up to one-third of patients and results from large-volume normal saline administration (saline has a chloride concentration of 154 mEq/L, well above normal serum chloride). The anion gap may close while the patient remains acidotic because the high-anion-gap acidosis converts to a normal-anion-gap (hyperchloremic) acidosis. This typically resolves spontaneously within 24–48 hours and does not require treatment, but it can confuse providers who are using anion gap alone to track resolution.

Other complications

• Acute kidney injury — from severe dehydration or rhabdomyolysis. Monitor urine output and serum creatinine closely.
• Cardiac arrhythmias — from potassium, magnesium, or phosphate imbalances. Maintain continuous cardiac monitoring.
• Venous thromboembolism — dehydration and immobility increase clotting risk. Apply sequential compression devices and consider prophylactic anticoagulation per institutional protocol.

Patient education for DKA prevention

Effective patient education reduces DKA recurrence. The most common preventable cause of DKA is insulin nonadherence, making education a high-priority nursing intervention before discharge.

Sick day rules

Illness increases insulin requirements — patients must never skip insulin doses during illness, even if they are eating less. Teach patients to check blood glucose every 4 hours when sick and to check urine or blood ketones if glucose exceeds 250 mg/dL. Adequate hydration during illness (8 oz sugar-free fluid per hour) helps prevent dehydration and supports renal ketone clearance.

Insulin adherence

Explore barriers to insulin adherence: cost, needle phobia, lifestyle disruption, insulin omission related to weight control. Address each barrier with specific resources. If cost is the primary barrier, connect the patient with social work or pharmaceutical patient assistance programs.

When to seek emergency care

Teach patients to go to the emergency department if they develop:

• Blood glucose >300 mg/dL that does not respond to correction doses
• Moderate or large ketones on home testing
• Persistent vomiting (inability to keep fluids down)
• Difficulty breathing or rapid breathing
• Confusion or difficulty staying awake

Home ketone monitoring

All patients with type 1 diabetes should have home ketone monitoring capability. Blood ketone meters (measuring beta-hydroxybutyrate) are more accurate and faster than urine ketone strips. Teach the target: blood ketones <0.6 mmol/L is normal, 0.6–1.5 mmol/L warrants increased fluids and insulin adjustment, and >1.5 mmol/L requires immediate medical contact.

High-yield NCLEX tips for DKA

• Potassium before insulin. If serum K+ is below 3.5 mEq/L, hold insulin and replace potassium first. Giving insulin to a hypokalemic patient can cause fatal arrhythmias. This is tested repeatedly on NCLEX.
• Kussmaul respirations are compensatory. Deep, rapid breathing in DKA is the body’s attempt to blow off CO2 and raise pH. Do not intervene to slow the breathing — it is a protective mechanism. Disappearance of Kussmaul breathing in a patient with persistent acidosis suggests clinical deterioration, not improvement.
• DKA = type 1, HHS = type 2 (as a general rule). DKA has ketones and acidosis. HHS has extreme hyperglycemia (>600 mg/dL) and hyperosmolality without significant ketosis. DKA presents rapidly; HHS develops over days to weeks.
• Fruity breath = acetone. Acetone is a volatile ketone body that is exhaled through the lungs. This finding is specific to DKA and does not occur in HHS.
• Normal saline first, insulin second. Fluid resuscitation begins immediately. Insulin is started after potassium levels are confirmed adequate. Fluids alone will lower blood glucose by 35–70 mg/dL per hour through dilution and improved renal clearance.
• Do not stop insulin when glucose normalizes. Insulin must continue until the anion gap closes. Add dextrose to IV fluids when glucose reaches 200–250 mg/dL to prevent hypoglycemia while clearing remaining ketones.
• Anion gap formula: Na+ − (Cl− + HCO3−). Normal is 8–12 mEq/L. An elevated anion gap in DKA reflects unmeasured ketone acids. Track the anion gap, not just glucose, to determine whether DKA has resolved.
• Cerebral edema is the most dangerous complication in pediatric DKA. Watch for sudden headache, vomiting, altered consciousness, and bradycardia during treatment. Rapid fluid administration and overcorrection of glucose are risk factors.
• Serum potassium appears falsely normal or high on admission. Despite massive total-body potassium depletion, acidosis shifts potassium extracellularly. This is the classic “look normal, be depleted” scenario. Always assume the patient needs potassium replacement.
• DKA resolution requires three criteria: glucose <200 mg/dL PLUS at least two of: bicarb ≥15, pH >7.3, anion gap ≤12. Overlap the IV-to-subcutaneous insulin transition by at least 2 hours to prevent rebound ketoacidosis.

Related pages

• Heart failure pathophysiology: a nursing reference guide — cardiac complications link to electrolyte management in DKA
• COPD pathophysiology: a complete nursing reference guide — respiratory acidosis concepts complement the metabolic acidosis in DKA
• Nursing lab values cheat sheet — BMP interpretation, anion gap, and electrolyte ranges
• EKG interpretation cheat sheet — recognizing electrolyte-related ECG changes during DKA treatment
• Electrolyte imbalances in nursing — potassium, magnesium, and phosphate management